<DOC>
	<DOC>NCT01592955</DOC>
	<brief_summary>The purpose of this study is to evaluate the effectiveness and the safety of the cyclocoagulation using High Intensity Focused Ulatrsound with the EYEOP1 device in glaucoma patients</brief_summary>
	<brief_title>Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU)</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<criteria>Refractory Glaucoma IOP &gt; 21 mm Hg No previous intraocular surgery or laser treatment during the 90 days before HIFU day Age &gt; 18 years Informed consent sgned by the subject Normal Tension Glaucoma Glaucoma drainage device implanted and still present in the eye to be treated History of ocular or retrobulbar tumor Ocular infection within 14 days prior to the HIFU procedure Aphakic patient Ocular disease other than glaucoma that may affect assessment of visual and/or IOP (choroidal hemorrhage or detachment, lens subluxation, thyroid ophthalmopathy, proliferative diabetic retinopathy, clinical significant macular edema) Pregnant or breastfeeding women, or lack of contraception use among women likely to have a child</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Cyclocoagulation</keyword>
	<keyword>HIFU High Intensity Focused Ultrasound</keyword>
</DOC>